Karyopharm Therapeutics Inc. (KPTI) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-17.93 | -28.1% |
| 2024 | $-14.00 | +25.5% |
| 2023 | $-18.79 | -830.2% |
| 2022 | $-2.02 | -22.4% |
| 2021 | $-1.65 | +39.3% |
| 2020 | $-2.72 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-17.93 | -28.1% |
| 2024 | $-14.00 | +25.5% |
| 2023 | $-18.79 | -830.2% |
| 2022 | $-2.02 | -22.4% |
| 2021 | $-1.65 | +39.3% |
| 2020 | $-2.72 | — |